---
url: https://www.servicesaustralia.gov.au/pb324
title: Rheumatoid arthritis - change of treatment after resolution of critical shortage of tocilizumab authority application form (PB324) - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-17T02:25:46.484Z
source: servicesaustralia.gov.au
---
# Rheumatoid arthritis - change of treatment after resolution of critical shortage of tocilizumab authority application form (PB324)

Use this form to apply for change of treatment from PBS-subsidised biological medicine to tocilizumab after resolution of critical shortage of tocilizumab for patients with rheumatoid arthritis.

How to use our forms

You must [download our forms and fill them in](/how-to-use-our-forms) so they are processed quickly. You can also electronically sign some of our forms. We have help available if you use assistive technology or need an interpreter.

You can [upload this form in HPOS](/upload-forms-hpos).

'Biological agent' refers to:

-   abatacept
-   adalimumab
-   baricitinib
-   certolizumab pegol
-   etanercept
-   golimumab
-   infliximab
-   rituximab
-   tofacitinib
-   upadacitinib.

Download and complete the [Rheumatoid arthritis - change of treatment after resolution of critical shortage of tocilizumab authority application form](/sites/default/files/pb324-2112en-f.pdf "PDF document").
